1. Home
  2. SNY vs STAK Comparison

SNY vs STAK Comparison

Compare SNY & STAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • STAK
  • Stock Information
  • Founded
  • SNY 1994
  • STAK 2020
  • Country
  • SNY France
  • STAK China
  • Employees
  • SNY N/A
  • STAK N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • STAK
  • Sector
  • SNY Health Care
  • STAK
  • Exchange
  • SNY Nasdaq
  • STAK NYSE
  • Market Cap
  • SNY 123.6B
  • STAK 20.8M
  • IPO Year
  • SNY N/A
  • STAK 2025
  • Fundamental
  • Price
  • SNY $53.63
  • STAK $2.75
  • Analyst Decision
  • SNY Buy
  • STAK
  • Analyst Count
  • SNY 2
  • STAK 0
  • Target Price
  • SNY $62.50
  • STAK N/A
  • AVG Volume (30 Days)
  • SNY 3.6M
  • STAK 1.9M
  • Earning Date
  • SNY 04-24-2025
  • STAK 01-01-0001
  • Dividend Yield
  • SNY 3.08%
  • STAK N/A
  • EPS Growth
  • SNY 39.56
  • STAK N/A
  • EPS
  • SNY 5.45
  • STAK 0.28
  • Revenue
  • SNY $48,817,552,946.00
  • STAK $22,248,609.00
  • Revenue This Year
  • SNY $5.35
  • STAK N/A
  • Revenue Next Year
  • SNY $6.69
  • STAK N/A
  • P/E Ratio
  • SNY $18.87
  • STAK $9.73
  • Revenue Growth
  • SNY N/A
  • STAK N/A
  • 52 Week Low
  • SNY $45.80
  • STAK $1.13
  • 52 Week High
  • SNY $60.12
  • STAK $4.53
  • Technical
  • Relative Strength Index (RSI)
  • SNY 50.20
  • STAK N/A
  • Support Level
  • SNY $50.46
  • STAK N/A
  • Resistance Level
  • SNY $51.64
  • STAK N/A
  • Average True Range (ATR)
  • SNY 1.60
  • STAK 0.00
  • MACD
  • SNY 0.15
  • STAK 0.00
  • Stochastic Oscillator
  • SNY 65.92
  • STAK 0.00

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About STAK STAK INC.

Stak Inc is engaged in research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment. It design and manufacture oilfield-specialized production and maintenance equipment and also sell oilfield-specialized production and maintenance equipment components, related products, and provide automation solutions. Its products include oilfield vehicles such as oil pumping trucks, oil-well repair trucks, fracking trucks, well flushing-wax removal trucks, and boiler trucks. The company also produce specialized equipment and components for oil well repair and maintenance, fracking, oil well cleaning and wax removal, oil pumping, and boilers.

Share on Social Networks: